RecruitingNCT06762379
Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy Integration
Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC
Sponsor
European Institute of Oncology
Enrollment
125 participants
Start Date
Dec 20, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Implementation of a new algorithm for HRR gene mutation testing in patients with mPC through liquid biopsy integration
Eligibility
Sex: MALEMin Age: 18 Years
Inclusion Criteria1
- Patients with metastatic prostate cancer whose tumor tissue is unavailable or inadequate for molecular testing. • Written informed consent must be signed and dated by the patient and the investigator prior to inclusion.
Exclusion Criteria1
- Unable to provide written informed consent
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06762379